Topic: BIOMARKERS IN MS

New consensus statement on MRI biomarkers in MS

February 20, 2024  

McDonald criteria 2024: what changes can we expect?

January 30, 2024  

NfL a marker of microglial activation

December 6, 2023  

Biomarkers after stopping treatment may identify at-risk MS patients

November 30, 2023  

Neurofilament-light chain (NfL) as a biomarker of response to higher-efficacy disease-modifying therapies

November 22, 2023  

OCT – diagnosis and prognosis

November 8, 2023  

ECTRIMS-ACTRIMS 2023 HIGHLIGHTS – FRIDAY, OCTOBER 13 EDITION

October 13, 2023  

ECTRIMS-ACTRIMS 2023 HIGHLIGHTS – WEDNESDAY, OCTOBER 11 EDITION

October 11, 2023  

EYE TRACKING AS A BIOMARKER OF MS SEVERITY (NEUROSOUND PODCAST)

October 3, 2023  

K-index a predictor of T2 lesions in CIS, RIS

September 14, 2023